Despite major advances in neonatal care during the past few decades, bacterial sepsis continues to be a major cause of mortality and morbidity in preterm very low birth weight (VLBW) infants. 1, 2 ...

Although clinical trials have demonstrated the utility of procalcitonin (PCT) testing and potential benefit on antibiotic stewardship, findings suggest that clinicians do not order PCT testing with ...

Since its emergence in December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of COVID-19, has already infected more than 92 million people and claimed ...

Respiratory tract infections (RTIs) are among the most common reasons for antibiotic prescription in primary care. A test that can differentiate between bacterial and viral RTIs could help to reduce ...

Treatment with antibodies against T-lymphocytes usually triggers a febrile response potentially mimicking or masking infection. Procalcitonin (PCT) is considered a sensitive and specific marker of ...

The early diagnosis of sepsis is necessary to help patients and prevent the unnecessary use of antimicrobial agents. This serious condition, resulting from harmful micro-organisms in the blood or ...

Made up of a protein structure containing 116 amino acids, procalcitonin acts as a substrate for production of calcitonin – a hormone responsible for producing C-cells of the thyroid gland and ...

Credit: Getty Images. Among 140 patients included in the analysis, 56.4% had serum procalcitonin levels of less than 0.5 ng/mL, while 43.6% had levels of 0.5 ng/mL or higher. Elevated serum ...

Background: Procalcitonin (PCT) is an effective and sensitive diagnostic biomarker that can facilitate the early detection of infection and septicemia, but whether it can similarly be utilized to ...

Emergency physicians do not commonly use the tools available for risk stratifying patients with febrile neutropenia. Most decide to admit these patients, even when they are considered to be at low ...

The worldwide procalcitonin (PCT) assay market share is anticipated to grow rapidly, with a projected market value of US$ 280.6 million in 2023 and an anticipated CAGR of 6.2% over the forecast period ...